No profile data available.
Benitec Biopharma Inc. (BNTC) is a healthcare company in the brain and nerve treatment drugs industry, based in Hayward, United States, with about 24 full-time employees.
It reported revenue of $0 for fiscal year 2026, and net income of -$45.55 million. Its market capitalization was $309.41 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended June 30, 2026; market data as of October 9, 2026.
, a clinical-stage biotechnology company, focuses on the development of novel genetic medicines in the United States.
Benitec Biopharma reported $0 in revenue for fiscal year 2026.
$309.41 million as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Capricor Therapeutics, Inc. (CAPR), Prothena Corporation plc (PRTA), Relmada Therapeutics, Inc. (RLMD), Fulcrum Therapeutics, Inc. (FULC).